EUVIMEDEUVIMED entdecken
Studienprotokoll

The Trajectories of Neuromuscular Aging ( TRAJECTOR ‐ AGE Clinical Trial): Study Rationale and Methodological Protocol

Fulvio Lauretani, Marcello Maggio, Andrea M Pilotto iD, Massimiliano Ansaldo, Clarissa M Brusco, Marco Carbonaro, Caterina Amendola, Marco Nabacino iD, Crescenzo Testa, Andrea Ciuni, Nicola Sverzellati, Irene Zucchini und 6 weitere

Journal of the American Geriatrics Society · 2025

DOI: 10.1111/jgs.70005 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Journal of the American Geriatrics Society, 2025. Verfasst von Fulvio Lauretani und 17 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Clinic Unit, Medical Geriatric Rehabilitative Department, University Hospital of Parma, Parma, Italy. Hauptthemen laut MEDLINE: Aging, Neuromuscular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: PRIN (PROGETTI DI RICERCA DI RILEVANTE INTERESSE NAZIONALE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To examine the structural, metabolic, and functional trajectories of neuromuscular decline in aging and identify key mechanisms and early biomarkers to guide interventions preserving function and independence.

Design

The TRAJECTOR‐AGE project is a prospective, longitudinal cohort study conducted over 2 years across multiple centers in Italy. Setting and Participants Community‐dwelling, physically and cognitively healthy middle‐aged (50–60 years) and older (> 70 years) adults are recruited. Individuals with significant comorbidities (e.g., diabetes, neurological disorders, severe heart failure) are excluded.

Measurements

Participants undergo comprehensive clinical and physiological evaluations every 6 months, including assessments of geriatric status, body composition, cardiovascular function, and neuromuscular performance. Imaging includes periodic quadriceps ultrasound and annual multiparametric MRI to assess muscle volume and fat infiltration. Biological samples (blood, urine and Vastus lateralis muscle biopsy) are collected yearly to evaluate inflammatory, metabolic, and neuromuscular biomarkers. Expected Results By integrating clinical, functional, and molecular data over time, the TRAJECTOR‐AGE study aims to clarify the pathophysiological mechanisms underlying neuromuscular decline, capture inter‐individual variability, and explore the influence of habitual physical activity on aging trajectories.

Conclusions

This multidimensional approach may enable earlier identification of individuals at risk for functional decline and inform the development of targeted preventive or therapeutic interventions to promote independence and healthy aging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingNeuromuscular DiseasesHumansAgedMiddle AgedProspective StudiesLongitudinal StudiesMaleFemaleItalyGeriatric AssessmentBiomarkersMagnetic Resonance ImagingQuadriceps MuscleIndependent LivingBody Composition

Stichwörter der Autor:innen

cognitive frailtymotor functionmuscle agingneuromuscular declinephysical frailty

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Geriatric Clinic Unit, Medical Geriatric Rehabilitative Department, University Hospital of Parma, Parma, Italy.
  • Department of Medicine and Surgery, University of Parma (UNIPR), Parma, Italy.
  • Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Department of Biomedical Sciences, University of Padova (UNIPD), Padova, Italy.
  • Laboratory for Engineering of the Neuromuscular System (LISiN), Department of Electronics and Telecommunications, Politecnico di Torino (POLITO), Torino, Italy.
  • Institute of Intelligent Industrial Technologies and Systems for Advanced Manufacturing, National Research Council (CNR), Milan, Italy.

ORCID-Profile: Andrea M Pilotto, Marco Nabacino

Förderung

  • PRIN (PROGETTI DI RICERCA DI RILEVANTE INTERESSE NAZIONALE)

Zitieren

APA

Lauretani, F., Maggio, M., Pilotto, A. M., Ansaldo, M., Brusco, C. M., Carbonaro, M., Amendola, C., Nabacino, M., Testa, C., Ciuni, A., Sverzellati, N., Zucchini, I., Salvi, M., Mastropietro, A., Re, R., Botter, A., Franchi, M. V., & Porcelli, S. (2025). The Trajectories of Neuromuscular Aging ( TRAJECTOR ‐ AGE Clinical Trial): Study Rationale and Methodological Protocol. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.70005

Vancouver

Lauretani F, Maggio M, Pilotto AM, Ansaldo M, Brusco CM, Carbonaro M, et al. The Trajectories of Neuromuscular Aging ( TRAJECTOR ‐ AGE Clinical Trial): Study Rationale and Methodological Protocol. Journal of the American Geriatrics Society. 2025. doi:10.1111/jgs.70005

BibTeX
@article{Lauretani2025,
  author = {Lauretani, Fulvio and Maggio, Marcello and Pilotto, Andrea M and Ansaldo, Massimiliano and Brusco, Clarissa M and Carbonaro, Marco and Amendola, Caterina and Nabacino, Marco and Testa, Crescenzo and Ciuni, Andrea and Sverzellati, Nicola and Zucchini, Irene and Salvi, Marco and Mastropietro, Alfonso and Re, Rebecca and Botter, Alberto and Franchi, Martino V and Porcelli, Simone},
  title = {The Trajectories of Neuromuscular Aging ( TRAJECTOR ‐ AGE Clinical Trial): Study Rationale and Methodological Protocol},
  journal = {Journal of the American Geriatrics Society},
  year = {2025},
  doi = {10.1111/jgs.70005}
}
Kostenlos starten →